<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29421495</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-5492</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><PubDate><Year>2018</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Transplant immunology</Title><ISOAbbreviation>Transpl Immunol</ISOAbbreviation></Journal><ArticleTitle>The prevalence of HLA alleles in a lupus nephritis population.</ArticleTitle><Pagination><StartPage>37</StartPage><EndPage>43</EndPage><MedlinePgn>37-43</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.trim.2018.02.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0966-3274(17)30090-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">Systemic lupus erythematosus (SLE) is a severe autoimmune disease that involves multiple organ systems. Lupus nephritis (LN) is a complication of SLE and is associated with poor survival and high morbidity. Many genomic studies have been performed worldwide, and several histocompatibility leukocyte antigen (HLA) loci are linked to lupus susceptibility.</AbstractText><AbstractText Label="OBJECTIVE">The present study evaluated the association of HLA alleles in a lupus patient population, LN group and control group. The second objective evaluated whether HLA allele match or mismatch influenced kidney graft survival in a kidney transplanted lupus population.</AbstractText><AbstractText Label="METHODS">This study was a retrospective study of 2 major groups: general lupus patients (GSLE - n&#x202f;=&#x202f;108) and a control group (GControl - n&#x202f;=&#x202f;216). Both groups were also divided into subgroups.</AbstractText><AbstractText Label="RESULTS">The control group was divided into two subgroups: a healthy control group (HeCTRL) and transplant control group (TxCTRL). The GSLE group was composed of transplanted lupus patients (TxSLE) and non-transplanted lupus patients (nTxSLE). Comparison of the demographics between groups did not reveal differences between ethnicity and gender. A difference in the prevalence of three alleles, B*08, DRB1*08 and DRB1*15, was observed. These alleles were more prevalent in the lupus subgroups compared to the control groups. Five-year survival was not different between patients carrying the allele DRB1*15 in either group (overall p&#x202f;=&#x202f;0.075; TxSLE p&#x202f;=&#x202f;0.419; TxCTRL&#x202f;=&#x202f;0.309). The presence of the match with this allele in the receptor was evaluated and did not demonstrate any difference in graft survival in both groups (p&#x202f;=&#x202f;0.146) or when analyzed separately in each group (TxCTRL p&#x202f;=&#x202f;0.739; TxSLE&#x202f;=&#x202f;0.297).</AbstractText><AbstractText Label="CONCLUSION">This study demonstrated that the presence of HLA-DRB1*15 was a strong factor that predisposed patients to the development of SLE and LN, but did not influence kidney graft survival.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Holanda</LastName><ForeName>Maria Izabel</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Nephrology Service, Hospital Federal de Bonsucesso, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klumb</LastName><ForeName>Evandro</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Rheumatology Service, Rio de Janeiro State University, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Imada</LastName><ForeName>Alicia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nephrology Service, Hospital Federal de Bonsucesso, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lima</LastName><ForeName>Livia A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Nephrology Service, Hospital Federal de Bonsucesso, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alc&#xe2;ntara</LastName><ForeName>Isabela</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Nephrology Service, Hospital Federal de Bonsucesso, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greg&#xf3;rio</LastName><ForeName>Flavia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Nephrology Service, Hospital Federal de Bonsucesso, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christiani</LastName><ForeName>Luis Fernando</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Nephrology Service, Hospital Federal de Bonsucesso, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Clarice Oliveira</ForeName><Initials>CO</Initials><AffiliationInfo><Affiliation>Rheumatology Service, Rio de Janeiro State University, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Timoner</LastName><ForeName>Branca Engel</ForeName><Initials>BE</Initials><AffiliationInfo><Affiliation>Histocompatibility and Cryopreservation Laboratory, Rio de Janeiro State University, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Motta</LastName><ForeName>Juliana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Histocompatibility and Cryopreservation Laboratory, Rio de Janeiro State University, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pozzan</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiology Service, Rio de Janeiro State University, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xf4;rto</LastName><ForeName>Luis Crist&#xf3;v&#xe3;o</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Histocompatibility and Cryopreservation Laboratory, Rio de Janeiro State University, Brazil. Electronic address: lcporto@uerj.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Transpl Immunol</MedlineTA><NlmUniqueID>9309923</NlmUniqueID><ISSNLinking>0966-3274</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006680">HLA Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059811">HLA-DRB1 Chains</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C507799">HLA-DRB1*15 antigen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005006" MajorTopicYN="N">Ethnicity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="Y">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006084" MajorTopicYN="N">Graft Rejection</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006085" MajorTopicYN="N">Graft Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006680" MajorTopicYN="N">HLA Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059811" MajorTopicYN="N">HLA-DRB1 Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016030" MajorTopicYN="Y">Kidney Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="N">Lupus Nephritis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011110" MajorTopicYN="N">Polymorphism, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29421495</ArticleId><ArticleId IdType="doi">10.1016/j.trim.2018.02.001</ArticleId><ArticleId IdType="pii">S0966-3274(17)30090-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>